Inside Tilray's First Big Earnings Report: Bull vs. Bear
Elon Musk isn't the only one getting high lately.
Tilray Inc. (TLRY) , the medical marijuana company is up 800% since its IPO at $17 in July of this year. Shares rose 29% to $154.98 on Tuesday alone.
The products in the world of marijuana can be confusing. There's CBD, TCH, different blends, and different forms in which to take it. Investors can be forgiven for feeling they are deep in the weeds trying to understand the product base.
Here's a run-down and visual of Tilray's products.
Tilray offers medical marijuana in the form of ingestible oil and dried flower. The oil drops come in a small bottle, with a price range of $44 to $108.
CBD Dominant
This can be taken in the form of oil, capsule, or dried flower.
The CBD dominant oil products have a range of 22.7 milligrams to 25.1 milligrams of CBD, and a range of 1 to 5.7 milligrams of THC per dose.
The capsule product has 17.7 milligrams of CBD and 4.7 milligrams of THC.
There is no CBD dominant flower product.
THC Dominant
This can be taken in the form of oil and flower, but not capsule. The THC dominant oil product has 23.3 milligrams of THC and .1 milligrams of CBD. The flower forms have a range of 15.3% THC to 26.3%, and all have 0.1% CBD.
Balance
These products have a more equal weighting of CBD and THC in them. The oil form has 10.4 milligrams of THC and 10 milligrams of CBD. The capsule form has 9.5 milligrams of THC and 10.7 milligrams of CBD. The flower form has 12.2 THC and 12.9% CBD.
Here's a graphic of what's what, and what the different chemical extracts in the products do to the system.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.